Merit Medical Valuation
| MMSI Stock | USD 82.50 2.87 3.60% |
At this time, the firm appears to be undervalued. Merit Medical Systems secures a last-minute Real Value of $94.13 per share. The latest price of the firm is $82.5. Our model forecasts the value of Merit Medical Systems from analyzing the firm fundamentals such as Current Valuation of 5.13 B, profit margin of 0.08 %, and Return On Equity of 0.083 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Merit Medical's valuation include:
Price Book 3.0769 | Enterprise Value | Enterprise Value Ebitda 16.4028 | Price Sales 3.1963 | Forward PE 20.0401 |
Undervalued
Today
Please note that Merit Medical's price fluctuation is very steady at this time. Calculation of the real value of Merit Medical Systems is based on 3 months time horizon. Increasing Merit Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Merit Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Merit Stock. However, Merit Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 82.5 | Real 94.13 | Target 104.0 | Hype 81.98 | Naive 84.68 |
The intrinsic value of Merit Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Merit Medical's stock price.
Estimating the potential upside or downside of Merit Medical Systems helps investors to forecast how Merit stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Merit Medical more accurately as focusing exclusively on Merit Medical's fundamentals will not take into account other important factors: When choosing an evaluation method for Merit Medical Systems, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Merit Medical Cash |
|
Merit Revenue by Product
Merit Medical Total Value Analysis
Merit Medical Systems is now projected to have valuation of 5.13 B with market capitalization of 4.72 B, debt of 794.66 M, and cash on hands of 51.48 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Merit Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.13 B | 4.72 B | 794.66 M | 51.48 M |
Merit Medical Investor Information
About 98.0% of the company shares are owned by institutional investors. The book value of Merit Medical was now reported as 25.8. The company has Price/Earnings To Growth (PEG) ratio of 1.67. Merit Medical Systems had not issued any dividends in recent years. The entity had 5:4 split on the 6th of May 2011. Merit Medical Systems may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 266.6 M | 253.9 M |
|
|
Merit Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Merit Medical has an asset utilization ratio of 56.09 percent. This signifies that the Company is making $0.56 for each dollar of assets. An increasing asset utilization means that Merit Medical Systems is more efficient with each dollar of assets it utilizes for everyday operations.Merit Medical Profitability Analysis
Taking into consideration Merit Medical's profitability measurements, Merit Medical Systems may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Merit Medical's ability to earn profits and add value for shareholders.Net Income | First Reported 1989-03-31 | Previous Quarter 32.6 M | Current Value 27.8 M | Quarterly Volatility 8.3 M |
For Merit Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Merit Medical Systems to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Merit Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Merit Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Merit Medical over time as well as its relative position and ranking within its peers.
Merit Medical Earnings per Share Projection vs Actual
The next projected EPS of Merit Medical is estimated to be 1.011575 with future projections ranging from a low of 0.9675 to a high of 1.06. Merit Medical's most recent 12-month trailing earnings per share (EPS TTM) is at 1.96. Please be aware that the consensus of earnings estimates for Merit Medical Systems is based on EPS before non-recurring items and includes expenses related to employee stock options.Merit Medical Earnings Estimation Breakdown
The calculation of Merit Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Merit Medical is estimated to be 1.011575 with the future projection ranging from a low of 0.9675 to a high of 1.06. Please be aware that this consensus of annual earnings estimates for Merit Medical Systems is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.97 Lowest | Expected EPS | 1.06 Highest |
Merit Medical Earnings Projection Consensus
Suppose the current estimates of Merit Medical's value are higher than the current market price of the Merit Medical stock. In this case, investors may conclude that Merit Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Merit Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 10 | 83.6% | 0.0 | 1.011575 | 1.96 |
Merit Medical Ownership Allocation
The majority of Merit Medical outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merit Medical Systems to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merit Medical Systems. Please pay attention to any change in the institutional holdings of Merit Medical as this could imply that something significant has changed or is about to change at the company.Merit Medical Profitability Analysis
The company reported the previous year's revenue of 1.36 B. Net Income was 120.36 M with profit before overhead, payroll, taxes, and interest of 715.9 M.About Merit Medical Valuation
An absolute valuation paradigm, as applied to Merit Stock, attempts to find the value of Merit Medical Systems based on its fundamental and basic technical indicators. By analyzing Merit Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Merit Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Merit Medical. We calculate exposure to Merit Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Merit Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 739.8 M | 776.8 M | |
| Pretax Profit Margin | 0.10 | 0.06 | |
| Operating Profit Margin | 0.10 | 0.06 | |
| Net Profit Margin | 0.08 | 0.08 | |
| Gross Profit Margin | 0.43 | 0.34 |
Merit Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 59.4 M | |
| Quarterly Earnings Growth Y O Y | -0.042 | |
| Forward Price Earnings | 20.0401 |
Merit Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Merit Medical Systems and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Merit we look at many different elements of the entity such as Merit's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Merit Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Merit Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Merit Medical's worth.Complementary Tools for Merit Stock analysis
When running Merit Medical's price analysis, check to measure Merit Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merit Medical is operating at the current time. Most of Merit Medical's value examination focuses on studying past and present price action to predict the probability of Merit Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merit Medical's price. Additionally, you may evaluate how the addition of Merit Medical to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |